Internal Reference Number: FOI_8891
Date Request Received: 08/09/2025 00:00:00
Date Request Replied To: 17/09/2025 00:00:00
This response was sent via: By Email
Request Summary: Biologics Rheumatology
Request Category: Companies
| Question Number 1: Could you please provide the numbers of patients treated by the rheumatology department (for any condition) in the last 3 months with the following drugs: Abatacept [Orencia] Adalimumab [Humira] Adalimumab Biosimilars Apremilast [Otezla] Baricitinib [Olumiant] Bimekizumab [Bimzelx] Certolizumab [Cimzia] Etanercept [Enbrel] Etanercept Biosimilars Filgotinib [Jyseleca] Golimumab [Simponi] Guselkumab [Tremfya] Infliximab [Remicade] Infliximab Biosimilars Ixekizumab [Taltz] Risankizumab [Skyrizi] Rituximab [MabThera] Rituximab Biosimilars Sarilumab [Kevzara] Secukinumab [Cosentyx] Tocilizumab [Ro Actemra] Tocilizumab Biosimilars Tofacitinib [Xeljanz] Upadacitinib [Rinvoq] Ustekinumab [Stelara] Ustekinumab Biosimilar | |
| Answer To Question 1: Please see our response to all questions in the file attached. To accompany this answer to question 1 please also see the documents listed below:  13237 - FOI_8891 - Biologics Rheumatology - FOR ISSUE.xlsx | |
| Question Number 2: Could you please provide the numbers of patients treated for Psoriatic Arthritis (PsA) ONLY in the last 3 months with the following drugs. Abatacept [Orencia] Adalimumab [Humira] Adalimumab Biosimilars Apremilast [Otezla] Bimekizumab [Bimzelx] Certolizumab [Cimzia] Etanercept [Enbrel] Etanercept Biosimilars Golimumab [Simponi] Guselkumab [Tremfya] Infliximab [Remicade] Infliximab Biosimilars Ixekizumab [Taltz] Risankizumab [Skyrizi] Secukinumab [Cosentyx] Tofacitinib [Xeljanz] Upadacitinib [Rinvoq] Ustekinumab [Stelara] Ustekinumab Biosimilar | |
| Answer To Question 2: Please see our response to all questions in the file attached. | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at SA国际传媒 Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
